ENDOTHELIN RECEPTOR--PURIFICATION AND CHARACTERIZATION
ENDOTHELIN RECEPTOR--PURIFICATION AND CHARACTERIZATION
批准号:
3087702
负责人:
MICHAEL D GUNN
金额:
$6.46万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-08-01 至 1994-07-31
关键词:
Xenopus affinity chromatography biological signal transduction blood vessel disorder calcium flux chemical structure function cow gel electrophoresis heart cell high performance liquid chromatography hypertension ion exchange chromatography molecular cloning muscle tone nuclear magnetic resonance spectroscopy nucleic acid probes peptide chemical synthesis protein purification protein structure function pulmonary hypertension radionuclides receptor binding receptor expression site directed mutagenesis tissue /cell culture vascular resistance vascular smooth muscle vasoconstrictors vasospasm
中文摘要
许多心血管疾病涉及血管张力的改变,
血液流动的阻力。 这些包括全身和肺部
高血压和急性冠状动脉和脑动脉血管痉挛。 现在
已知血管内皮细胞产生重要的血管调节作用,
调节血管平滑肌张力的物质。 一种这样的物质
是内皮素,迄今为止已知的最有效的血管收缩多肽。
本提案的长期目标是了解
内皮素在血管疾病中的作用,并开发阻断其作用的方法。
病理影响。
内皮素通过与血管内皮细胞表面上的高亲和力受体结合而起作用。
血管平滑肌细胞 该项目的目的是净化
内皮素受体,并利用其研究内皮素的作用机制
行动上 为了做到这一点,我们的具体目标是确定
内皮素分子的重要结构特征,以确定
各种组织的内皮素结合特性,纯化,
克隆内皮素受体,并对其进行测序,
研究内皮素信号通路的受体。 这项工作将
利用更新的生化技术,包括使用核
磁共振波谱法来确定
内皮素的结构和表达克隆作为分离内皮素的手段,
内皮素受体 我们有能力合成
内皮素衍生物,这可能允许特定的生产
内皮素拮抗剂。
初步研究表明,内皮素受体刺激
引起细胞内钙的显著增加,并可能与
打开电压激活的钙通道。定点
诱变将使我们能够研究这一机制和其他
对细胞生物学很重要的信号通路。 的结果予以
调查应更好地了解基本方面
内皮素的作用,并应有助于开发新的方法
血管疾病的研究和治疗。
英文摘要
Numerous cardiovascular diseases involve alterations in vascular tone and
resistance to blood flow. These include systemic and pulmonary
hypertension and acute coronary and cerebral artery vasospasm. It is now
known that the vascular endothelium produces important vaso-regulatory
substances which mediate vascular smooth muscle tone. One such substance
is endothelin, the most potent vasoconstrictor polypeptide known to date.
The long term goal of this proposal is to understand the role of
endothelin in vascular disease and to develop methods of blocking its
pathological effects.
Endothelin acts by binding to high affinity receptors on the surface of
vascular smooth muscle cells. The aim of this project is to purify the
endothelin receptor and use it to study the mechanism of endothelin
action. In order to do this, our specific aims are to determine the
important structural features of the endothelin molecule, to determine
the endothelin binding characteristics of various tissues, to purify,
clone, and sequence the endothelin receptor, and to use mutated forms of
the receptor to study endothelin's signaling pathways. This work will
utilize newer biochemical techniques including the use of nuclear
magnetic resonance spectroscopy to determine the three dimensional
structure of endothelin and expression cloning as a means to isolate the
endothelin receptor. We have the ability to synthesize functional
endothelin derivatives, which may allow the production of specific
endothelin antagonists.
Preliminary studies have shown that endothelin receptor stimulation
causes a marked increase in intracellular calcium and may be coupled to
opening of the voltage activated calcium channel. Site directed
mutagenesis will allow us to study the mechanism of this and other
signaling pathways important to cell biology. The results of these
investigations should provide a better understanding of the basic aspects
of endothelin action and should aid in the development of new approaches
to the study and treatment of vascular disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of point-of-care testing for Lassa and other hemorrhagic fever arenaviruses
-
批准号:10656548
-
项目类别:
-
资助金额:$39.7万
-
财政年份:2022
-
负责人:MICHAEL D GUNN
-
依托单位:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
-
批准号:10092930
-
项目类别:
-
资助金额:$19.73万
-
财政年份:2020
-
负责人:MICHAEL D GUNN
-
依托单位:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
-
批准号:9896170
-
项目类别:
-
资助金额:$23.77万
-
财政年份:2020
-
负责人:MICHAEL D GUNN
-
依托单位:
Project 2: A Novel Cellular Tumor Vaccine Strategy for Glioblastoma
-
批准号:10246886
-
项目类别:
-
资助金额:$56.58万
-
财政年份:2018
-
负责人:MICHAEL D GUNN
-
依托单位:
Project 2: A Novel Cellular Tumor Vaccine Strategy for Glioblastoma
-
批准号:10477339
-
项目类别:
-
资助金额:$56.47万
-
财政年份:2018
-
负责人:MICHAEL D GUNN
-
依托单位:
Project 2: A Novel Cellular Tumor Vaccine Strategy for Glioblastoma
-
批准号:10006178
-
项目类别:
-
资助金额:$52.12万
-
财政年份:2018
-
负责人:MICHAEL D GUNN
-
依托单位:
Generation of Zika virus-specific recombinant antibodies
-
批准号:9226804
-
项目类别:
-
资助金额:$23.85万
-
财政年份:2016
-
负责人:MICHAEL D GUNN
-
依托单位:
Generation of Zika virus-specific recombinant antibodies
-
批准号:9331436
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2016
-
负责人:MICHAEL D GUNN
-
依托单位:
A novel cellular tumor vaccine strategy for mutant IDH1 glioma
-
批准号:10248330
-
项目类别:
-
资助金额:$16.09万
-
财政年份:2014
-
负责人:MICHAEL D GUNN
-
依托单位:
A novel cellular tumor vaccine strategy for mutant IDH1 glioma
-
批准号:10248318
-
项目类别:
-
资助金额:$16.79万
-
财政年份:2014
-
负责人:MICHAEL D GUNN
-
依托单位:
A novel cellular tumor vaccine strategy for mutant IDH1 glioma
-
批准号:10705246
-
项目类别:
-
资助金额:$29.12万
-
财政年份:2014
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Salmonella Single-chain Abs as serum diagnostics
-
批准号:8468639
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2012
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Salmonella Single-chain Abs as serum diagnostics
-
批准号:8871680
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2012
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Salmonella Single-chain Abs as serum diagnostics
-
批准号:8839873
-
项目类别:
-
资助金额:$42.27万
-
财政年份:2012
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Salmonella Single-chain Abs as serum diagnostics
-
批准号:8302016
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2012
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Aspergillus single chain Abs as serum and imaging diagnostics
-
批准号:7779310
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2010
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Aspergillus single chain Abs as serum and imaging diagnostics
-
批准号:8413658
-
项目类别:
-
资助金额:$46.25万
-
财政年份:2010
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Aspergillus single chain Abs as serum and imaging diagnostics
-
批准号:8434024
-
项目类别:
-
资助金额:$41.66万
-
财政年份:2010
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Aspergillus single chain Abs as serum and imaging diagnostics
-
批准号:8607110
-
项目类别:
-
资助金额:$45.07万
-
财政年份:2010
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Aspergillus single chain Abs as serum and imaging diagnostics
-
批准号:8008766
-
项目类别:
-
资助金额:$21.94万
-
财政年份:2010
-
负责人:MICHAEL D GUNN
-
依托单位:
海外基金